Results 81 to 90 of about 15,126 (225)

Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin [PDF]

open access: yes, 2017
What is the level of consciousness of the psychedelic state? Empirically, measures of neural signal diversity such as entropy and Lempel-Ziv (LZ) complexity score higher for wakeful rest than for states with lower conscious level like propofol-induced ...
A Hillebrand   +50 more
core   +1 more source

Evidence that 5‐HT2A receptor signalling efficacy and not biased agonism differentiates serotonergic psychedelic from non‐psychedelic drugs

open access: yesBritish Journal of Pharmacology, EarlyView.
Background and Purpose Serotonergic psychedelic drugs are under investigation as therapies for various psychiatric disorders, including major depression. Although serotonergic psychedelic drugs are 5‐HT2A receptor agonists, some such agonists are not psychedelic, potentially due to differences in 5‐HT2A receptor ligand bias or signalling efficacy. Here,
Aurelija Ippolito   +6 more
wiley   +1 more source

The Idealist View of Consciousness After Death [PDF]

open access: yes, 2016
To make educated guesses about what happens to consciousness upon bodily death, one has to have some understanding of the relationship between body and consciousness during life. This relationship, of course, reflects an ontology.
Kastrup, Bernardo
core  

Psychological variables implied in the therapeutic effect of ayahuasca: A contextual approach [PDF]

open access: yes, 2018
Ayahuasca is a psychedelic decoction originating from Amazonia. The ayahuasca-induced introspective experience has been shown to have potential benefits in the treatment of several pathologies, to protect mental health and to improve neuropsychological ...
Alcázar Córcoles, Miguel Ángel   +5 more
core   +1 more source

Mushroom, Psilocybin

open access: yes, 2014
false ; 2016-03-16T23:02 ...
unknown ( host institution )   +1 more
openaire   +2 more sources

Are we hallucinating or can psychedelic drugs modulate the immune system to control inflammation?

open access: yesBritish Journal of Pharmacology, EarlyView.
Psychedelic drugs that activate 5‐HT2A receptors have been long used for cultural, medicinal and recreational purposes. Interest in psychedelics for treating psychiatric disorders has resurged recently and is well documented; less well recognised are their anti‐inflammatory properties. Growing evidence now demonstrates that psychedelics modulate immune
Omar Qureshi   +10 more
wiley   +1 more source

Psilocybin links binocular rivalry switch rate to attention and subjective arousal levels in humans [PDF]

open access: yes, 2018
Rationale: Binocular rivalry occurs when different images are simultaneously presented to each eye. During continual viewing of this stimulus, the observer will experience repeated switches between visual awareness of the two images.
Carter, Olivia   +5 more
core  

Psychedelics as pharmacotherapeutics for substance use disorders: A scoping review on clinical trials and perspectives on underlying neurobiology

open access: yesBritish Journal of Pharmacology, EarlyView.
Theorized mechanism of dopamine homeostasis restoration in the nucleus accumbens core induced by a psychedelic intervention. Abstract Psychedelics have garnered great attention in recent years as treatments for major depressive disorder (MDD) and treatment‐resistant depression because of their ability to alter consciousness and afflicted cognitive ...
Lucas Wittenkeller   +3 more
wiley   +1 more source

Structural basis for psilocybin biosynthesis

open access: yesNature Communications
Psilocybin shows significant therapeutic potential for psilocybin-assisted psychotherapy in addressing various psychiatric conditions. The biosynthetic approach promises rapid and efficient production of psilocybin.
Chunyan Meng   +12 more
doaj   +1 more source

On the primacy and irreducible nature of first-person versus third-person information [PDF]

open access: yes, 2017
In\ua0this\ua0essay,\ua0we\ua0will\ua0support\ua0the\ua0claim\ua0that\ua0at\ua0the\ua0current\ua0level\ua0of\ua0scientific advancement\ua0a)\ua0some\ua0first-person\ua0accounts\ua0cannot\ua0be\ua0reduced\ua0to\ua0their third-person\ua0neural\ua0and ...
Facco, Enrico   +2 more
core   +2 more sources

Home - About - Disclaimer - Privacy